Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI

CONCLUSION: Dapagliflozin treatment for patients with STEMI combined with T2DM after PCI can improve cardiac function to certain extent, reduce inflammation, and will reduce the incidence of adverse cardiovascular outcomes.PMID:34691230 | PMC:PMC8536432 | DOI:10.1155/2021/9388562

Source: Evidence-based Complementary and Alternative Medicine - October 25, 2021 Category: Complementary Medicine Authors: LiMing Xue Xian Yuan Shuguang Zhang Xia Zhao Source Type: research